Westwood Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.26M Buy
6,600
+1,500
+29% +$258K 0.36% 25
2026
Q1
$861K Buy
+5,100
New +$872K 0.34% 25
2025
Q4
– Sell
-6,395
Closed -$923K – 113
2025
Q3
$923K Sell
6,395
-485
-7% -$66.2K 0.34% 27
2025
Q2
$870K Sell
6,880
-6,760
-50% -$830K 0.29% 31
2025
Q1
$1.74M Sell
13,640
-100
-0.7% -$13.6K 0.75% 21
2024
Q4
$1.82M Sell
13,740
-760
-5% -$107K 0.66% 19
2024
Q3
$2.11M Buy
14,500
+2,175
+18% +$315K 0.83% 18
2024
Q2
$1.69M Sell
12,325
-150
-1% -$20K 0.63% 22
2024
Q1
$1.71M Buy
12,475
+4,060
+48% +$554K 0.84% 17
2023
Q4
$1.14M Sell
8,415
-140
-2% -$17.1K 0.88% 19
2023
Q3
$1.05M Hold
8,555
– – 0.69% 23
2023
Q2
$1.09M Buy
8,555
+200
+2% +$26K 0.77% 22
2023
Q1
$1.08M Sell
8,355
-1,236
-13% -$162K 0.96% 19
2022
Q4
$1.26M Buy
9,591
+1,120
+13% +$145K 1.51% 13
2022
Q3
$991K Sell
8,471
-1,400
-14% -$174K 0.89% 16
2022
Q2
$1.16M Sell
9,871
-5,270
-35% -$626K 1.34% 11
2022
Q1
$1.97M Sell
15,141
-13,815
-48% -$1.8M 0.77% 16
2021
Q4
$4.42M Buy
+28,956
New +$4.48M 1.88% 15

Other funds holding IBB

Westwood Wealth Management's IBB Position: Q2 2026 in Review

Westwood Wealth Management increased its iShares Biotechnology ETF (IBB) stake by 29% in Q2 2026, buying an estimated $258K and bringing the position to 6,600 shares worth $1.26M. The position accounts for 0.36% of the portfolio, ranked #25.

Westwood Wealth Management first reported a position in IBB in Q4 2021 and has held it in 18 quarters since. The position peaked at $4.42M in Q4 2021. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Westwood Wealth Management held 6,600 shares of iShares Biotechnology ETF worth $1.26M as of Q2 2026.
  • Westwood Wealth Management bought 1,500 iShares Biotechnology ETF shares in Q2 2026, an estimated $258K.
  • iShares Biotechnology ETF made up 0.36% of Westwood Wealth Management's portfolio in Q2 2026, its #25 holding.
  • Westwood Wealth Management first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 18 quarters since.
  • Westwood Wealth Management's iShares Biotechnology ETF position peaked at $4.42M in Q4 2021.
  • 960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Westwood Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.